Arkolith/Insider Trading/ADVM/Form 4

Nicholson, C. David

DirectorAdverum Biotechnologies, Inc. (ADVM) · full profile →Form 4 · filed Dec 10, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
0 non-derivative · 3 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 9, 2025Disposed to issuer(D)8K——0
Dec 9, 2025Disposed to issuer(D)11K——0
Dec 9, 2025Disposed to issuer(D)10K——0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001636168-25-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML